The Credent Connect N Care IPO concluded with a massive 142.38x subscription, drawing bids worth approximately ₹9,590 crore. Investors are now awaiting the share allotment process scheduled for August 18, followed by the company's debut on the NSE Emerge platform on August 20.
The initial public offering of Credent Connect N Care has concluded, receiving an overwhelming response from the market. The issue was oversubscribed 142.38 times, with total bids reaching nearly ₹9,590 crore against the company's goal to raise ₹93.9 crore. The subscription window was open from August 13 to August 17.
Investor interest was strong across categories. Non-institutional investors were particularly active, subscribing to their quota 217.3 times. Retail investors also showed significant participation, with their portion subscribed 138.85 times, while qualified institutional buyers subscribed 130.39 times.
Credent Connect N Care is a Delhi-based company that provides business-to-business healthcare logistics, specifically focusing on transporting diagnostic samples and reagents. As of June 2026, the company operated a fleet of 97 commercial vehicles and managed two warehouses. The company intends to use the funds raised from the IPO for working capital, repayment of debt, and capital spending for its subsidiary, Credent Healthcare.
Market participants have taken note of the company's key backers. Pre-IPO investors include prominent market names such as Ashish Kacholia, who holds a 2.02% stake, and Sunil Singhania's Abakkus Venture Opportunities Fund, which holds 2.26%. Such involvement often draws additional attention during the subscription phase.
While the grey market premium, which was recently tracked at approximately ₹55, suggests a positive sentiment among traders, investors should keep in mind that the grey market is an unofficial channel. It does not always predict the final listing performance. SME IPOs, particularly those listed on platforms like NSE Emerge, can experience higher price volatility compared to mainboard listings due to lower liquidity and specific market regulations.
Allotment of shares is expected to be finalized on August 18, 2026. Following this, the company's shares are scheduled to list on the stock exchange on August 20, 2026. The future financial performance of the company will depend on its ability to manage its fleet effectively, control costs associated with its subsidiary's capital projects, and maintain demand for its logistics services within the competitive healthcare diagnostics sector.